Articles From: Finning to Announce Q1 2014 Results and Hold Annual General Meeting on May 13, 2014; Investor Call on May 14, 2014 to IntelliCell BioSciences' Stromal Vascular Cell Technology Used For Restorative Cardiac Function With Dr. Zain Khalpey


http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0942074001&sourceType=1 http://www.ccnmatthews.com/logos/20110920-FINNING%20LARGE.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Finning to Announce Q1 2014 Results and Hold Annual General Meeting on May 13, 2014; Investor Call on May 14, 2014 investment picks
Live Webcasts from Las Vegas on May 15th and New York on May 20th SAN DIEGO , May 8, 2014 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP) , an oncology company focused on the clinical development of novel therapies for cancer, announced today that Daniel P.
Sign-up for MEI Pharma to Present at Bank of America Merrill Lynch and UBS Healthcare Conferences investment picks
NEW YORK (MarketWatch) -- Shares of Sallie Mae (SLM) fell about 20% in premarket trade Thursday, after the spinoff of its loan-management, servicing and asset-recovery business.
Sign-up for Sallie Mae shares fall following spinoff of loan management business investment picks
ATHENS, Greece , May 12, 2014 /PRNewswire/ -- Paragon Shipping Inc. (NASDAQ: PRGN) ("Paragon Shipping" or the "Company"), a global shipping transportation company specializing in drybulk cargoes, announced today that it will release its results for the first quarter ended March 31, 2014 , after the market closes in New York on Monday, May 19, 2014 .
Sign-up for Paragon Shipping Announces Date For The Release Of First Quarter 2014 Results, Conference Call And Webcast investment picks
SOUTH SAN FRANCISCO, Calif., May 12, 2014 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq:AKAO) , a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant (MDR) gram-negative infections, today reported financial results for the quarter ended March 31, 2014.
Sign-up for Achaogen Announces First Quarter 2014 Results investment picks
Achieved Primary Endpoint of Complete Response (CR) in the Delayed Period (24 to 120 Hours) Following Initiation of Chemotherapy Achieved Key Secondary Endpoints of CR in the Acute and Overall Periods Achieved All Secondary Endpoints, Including No Significant Nausea Adverse Event Profile Consistent with Earlier Clinical Trials New Drug Application (NDA) Submission to U.S. FDA On Track for Mid-2014 WALTHAM, Mass., May 12, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) , an oncology-focused biopharmaceutical company, today announced positive top-line results from the third and final Phase 3 trial of rolapitant, an investigational neurokinin-1 (NK-1) receptor antagonist in development for the prevention of chemotherapy-induced nausea and vomiting (CINV). The rolapitant arm in this trial, which enrolled patients receiving cisplatin-based, highly emetogenic chemotherapy (HEC), successfully achieved statistical significance over the standard
Sign-up for TESARO Announces Successful Achievement of Primary and All Secondary Endpoints in Third and Final Phase 3 Trial of Rolapitant investment picks
The world's smallest 5-mode LTE Advanced Carrier Aggregation modem, the Ericsson M7450, is fully tested and certified by China Mobile First devices integrating the Ericsson M7450 will be on the market in the second half of this year STOCKHOLM, Sweden, May 12, 2014 (GLOBE NEWSWIRE) -- Ericsson (NASDAQ: ERIC) today announced that the M7450 5-mode modem chipset, covering all five access technologies (TD-LTE, LTE FDD, WCDMA, TD-SCDMA and GSM), has been fully tested and certified for use in China Mobile's network.
Sign-up for China Mobile certifies Ericsson's LTE advanced modem investment picks
BRIDGEPORT, Pa., April 30, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Volt Solar Systems, Inc. (OTCBB:VOLT) announced today that it has received word from FINRA that its name change from First Power and Light, Inc. will be effective at the open of the market on May 1, 2014.
Sign-up for VOLT Name Change Effective and New Sales and Construction Office Opened in Massachusetts investment picks
SAN DIEGO and WASHINGTON, April 30, 2014 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Pepco Holdings, Inc. (NYSE: POM) by Exelon Corporation (NYSE: EXC) .
Sign-up for Acquisition of Pepco Holdings, Inc. by Exelon Corporation May Not Be in Shareholders' Best Interests investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0942878001&sourceType=1 http://www.ccnmatthews.com/logos/20080605-TKLOGO2.JPG HAMILTON, BERMUDA --
Sign-up for Teekay Offshore Partners Announces First Quarter 2014 Earnings Results Conference Call investment picks
OMAHA, Neb.
Sign-up for Bansal to Become Valmont COO investment picks
SUGAR LAND, Texas , April 29, 2014 /PRNewswire/ -- Arabian American Development Co.
Sign-up for Arabian American Receives Permit for South Hampton Plant Expansion investment picks
KANSAS CITY, Mo.
Sign-up for Sustained Colder Winter Impacts Natural Gas Prices investment picks
Lodging Giant Releases Annual List of Prestigious 2014 Gold Hospitality Awards ROCKVILLE, Md.
Sign-up for Award-Winning Choice Hotels in the Midwest United States investment picks
BOSTON , April 30, 2014 /PRNewswire/ -- Eaton Vance Tax-Managed Buy-Write Opportunities Fund (NYSE: ETV) , today announced important information concerning its distribution declared in April 2014.
Sign-up for Eaton Vance Tax-Managed Buy-Write Opportunities Fund April 2014 Distribution investment picks
http://media.marketwire.com/attachments/201311/199832_SB-hrz-logo-Color.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1111214&ProfileId=051205&sourceType=1 MONTEBELLO, NY --
Sign-up for Sterling Bancorp Declares Quarterly Dividend of $0.07 per Share investment picks
Fully Implanted Device Represents New Treatment Option for Patients Unable to Use CPAP MINNEAPOLIS , May 1, 2014 /PRNewswire/ -- Inspire Medical Systems, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Inspire Upper Airway Stimulation (UAS) therapy for use in a subset of patients with moderate to severe Obstructive Sleep Apnea (OSA) who are unable to use Continuous Positive Airway Pressure (CPAP). Inspire therapy is a fully implanted neurostimulation device, the first of its kind for sleep apnea, that provides an alternative treatment that is proven, convenient and easy to use.
Sign-up for FDA Approves Inspire® Upper Airway Stimulation (UAS) Therapy for Obstructive Sleep Apnea investment picks
Veterans and others are urged to apply DETROIT , April 30, 2014 /PRNewswire/ -- DTE Energy (NYSE: DTE) is starting a new Boot Camp to train veterans and others to become employees in the company's electric operations area.
Sign-up for DTE Energy offers training for electric operations positions investment picks
TORONTO , May 7, 2014 /PRNewswire/ - Sun Life Financial Inc. (TSX: SLF) (NYSE: SLF) announced that the 11 nominees listed in the management information circular dated March 17, 2014 were elected as directors of Sun Life Financial.
Sign-up for Sun Life Financial announces election of directors investment picks
PHILADELPHIA , April 29, 2014 /PRNewswire/ -- Republic First Bancorp, Inc. (NASDAQ: FRBK) , the holding company for Republic Bank , today announced that Robert R.
Sign-up for Republic Bank Hires Store Manager for New Revolutionary Banking Store in Voorhees, N.J. investment picks
NEW YORK , April 29, 2014 /PRNewswire/ -- Levi & Korsinsky is investigating the Board of Directors of Susser Holdings Corporation ("Susser" or "the Company") (NYSE: SUSS) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Energy Transfer Partners, L.P. ("Energy Transfer"). Click here to learn more about the investigation: http://zlk.9nl.com/susser-holdings-suss , or call: 877-363-5972.
Sign-up for INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of Susser Holdings Corporation and Its Board of Directors In Connection With the Sale of the Company to Energy Transfer Partners, L.P. -- SUSS investment picks
NEWPORT NEWS, Va., April 29, 2014 (GLOBE NEWSWIRE) -- Huntington Ingalls Industries (NYSE:HII) announced today that Capt.
Sign-up for PHOTO RELEASE-- Huntington Ingalls Industries Appoints Jonathan Padfield as Corporate Director of Customer Affairs for Amphibious Programs investment picks
DECLARES 71st CONSECUTIVE QUARTERLY DIVIDEND ACTON, Mass.
Sign-up for Psychemedics Corporation Announces Record First Quarter Revenues investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1110517&ProfileId=051205&sourceType=1 MIAMI, FL --
Sign-up for Southern Trust Securities Announces Strategic Alliance investment picks
NEW YORK , April 29, 2014 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous Stromal Vascular Cells (SVCs) derived from the blood vessels found in adipose tissue, announced today that it supplied its Stromal Vascular Fraction Cells, manufactured using its patented ultrasonic technology, for the restoration of cardiac function at the University of Arizona College of Medicine, Tucson in collaboration with Dr.
Sign-up for IntelliCell BioSciences' Stromal Vascular Cell Technology Used For Restorative Cardiac Function With Dr. Zain Khalpey investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Finning to Announce Q1 2014 Results and Hold Annual General Meeting on May 13, 2014; Investor Call on May 14, 2014 to IntelliCell BioSciences' Stromal Vascular Cell Technology Used For Restorative Cardiac Function With Dr. Zain Khalpey
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry